ZIM Laboratories Limited (BOM:541400)

ZIM Laboratories Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Operating Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	58.38	121.65	172.46	244.35	145.5
Depreciation & Amortization	192.88	195.23	154.76	172.02	159.99
Other Amortization	6.9	5.9	4.76	2.67	0.34
Loss (Gain) From Sale of Assets	-25.17	-1.98	-4.7	-0.2	-0.57
Asset Writedown & Restructuring Costs	-	-	-	6.6	0.03
Stock-Based Compensation	11.35	13.54	-	-	-
Provision & Write-off of Bad Debts	5.49	14.07	9.26	7.91	0.55
Other Operating Activities	85.93	178.78	94.09	70.27	120.41
Change in Accounts Receivable	71.28	-89.92	-71.37	26.95	-19.9
Change in Inventory	-73.05	-52.07	-275.57	215.78	-209.37
Change in Accounts Payable	161.34	26.33	79.08	-364.66	295.07
Operating Cash Flow	495.34	411.55	162.78	381.68	492.06
Operating Cash Flow Growth	20.36%	152.82%	-57.35%	-22.43%	54.49%

Investing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-443.87	-407.98	-739.23	-366.68	-152.25
Sale of Property, Plant & Equipment	56.17	7.32	5.48	0.2	1.6
Investment in Securities	-177.53	0.85	3.13	3.6	-
Other Investing Activities	1.76	0.53	0.49	0.85	4.94
Investing Cash Flow	-563.48	-399.27	-730.13	-362.04	-145.71

Financing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Short-Term Debt Issued	68.39	-	321.55	55.92	-
Long-Term Debt Issued	223.34	246.24	281.47	183.53	270.7
Total Debt Issued	291.73	246.24	603.02	239.45	270.7
Short-Term Debt Repaid	-	-25.27	-	-	-273.79
Long-Term Debt Repaid	-254.31	-189.02	-146.56	-173.91	-311.56
Total Debt Repaid	-254.31	-214.28	-146.56	-173.91	-585.34
Net Debt Issued (Repaid)	37.42	31.96	456.45	65.54	-314.64
Issuance of Common Stock	350.78	-	214.02	-	-
Common Dividends Paid	-	-	-0.49	-0.59	-1.68
Other Financing Activities	-106.34	-123	-74.64	-59.5	-13.39
Financing Cash Flow	281.86	-91.05	595.34	5.46	-329.71

Net Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Foreign Exchange Rate Adjustments	18.03	2.23	3.8	4.9	3.64
Net Cash Flow	231.75	-76.54	31.8	30	20.28

Free Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	51.48	3.57	-576.45	15	339.81
Free Cash Flow Growth	1342.31%	-	-	-95.58%	33.92%
Free Cash Flow Margin	1.38%	0.09%	-15.68%	0.38%	10.19%
Free Cash Flow Per Share	1.05	0.07	-11.83	0.31	6.97
Levered Free Cash Flow	-153.52	-172.13	-669.13	-139.27	240.6
Unlevered Free Cash Flow	-78.05	-108.08	-632.37	-108.2	285.4

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	128.95	123	75.14	55.34	79.26
Cash Income Tax Paid	37.34	-10.76	25.84	71.49	4.29
Change in Working Capital	159.58	-115.66	-267.85	-121.93	65.81

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 26, 2026

Data Sources Report a data error